HPV vaccine: A cornerstone of female health

American Family Physician

Volumn 75, Issue 1, 2007, Pages 28-30

  Temte, Jonathan L ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIPHTHERIA PERTUSSIS TETANUS VACCINE; DIPHTHERIA TOXOID; MENINGOCOCCUS VACCINE; TDAP; TETANUS TOXOID; UNCLASSIFIED DRUG; WART VIRUS VACCINE;

DRUG DOSE REGIMEN; EDITORIAL; FEMALE; GENITAL TRACT INFECTION; HUMAN; HUMAN PAPILLOMA VIRUS INFECTION; HUMAN PAPILLOMAVIRUS TYPE 11; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN PAPILLOMAVIRUS TYPE 6; MEDICAL SOCIETY; PAPANICOLAOU TEST; PATHOGENESIS; PREVENTIVE MEDICINE; RISK REDUCTION; SEXUALLY TRANSMITTED DISEASE; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA IN SITU; VIRUS INFECTION; WOMEN'S HEALTH;

ADOLESCENT; ADULT; ALPHAPAPILLOMAVIRUS; FEMALE; HUMANS; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; PRACTICE GUIDELINES; SEXUALLY TRANSMITTED DISEASES, VIRAL; UNITED STATES; UTERINE CERVICAL NEOPLASMS;

EID: 33846101078     PISSN: 0002838X     EISSN: 0002838X     Source Type: Journal    
DOI: None     Document Type: Editorial

References (8)

1. Centers for Disease Control and Prevention. Advisory Committee on Immunization Practices. ACIP provisional recommendations for the use of quadrivalent HPV vaccine [Press release]. Accessed November 21, 2006, at: http://www.cdc.gov/nip/recs/provisional_recs./hpv.pdf.
2. Villa LL, Costa RL, Petta CA, Andrade RP, Ault KA, Giuliano AR, et al. Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial. Lancet Oncol 2005;6:271-8.
3. Winer RL, Lee SK, Hughes JP, Adam DE, Kiviat NB, Koutsky LA. Genital human papillomavirus infection: incidence and risk factors in a cohort of female university students [Published correction appears in Am J Epidemiol 2003;157:858]. Am J Epidemiol 2003;157:218-26.
4. Eaton DK, Kann L Kinchen S, Ross J, Hawkins J, Harris WA, et al. Youth risk behavior surveillance-United States, 2005. MMWR Surveill Summ 2006;55:1-108.
5. Weinstock H, Berman S, Cates W Jr. Sexually transmitted diseases among American youth: incidence and prevalence estimates, 2000. Perspect Sex Reprod Health 2004;36:6-10.
6. Centers for Disease Control and Prevention. Screening to prevent cancer deaths. Accessed October 12, 2006, at: http://www.cdc.gov/nccdphp/publications/ factsheets/Prevention/cancer.htm.
7. Shepherd J, Weston R, Peersman G, Napuli IZ. Interventions for encouraging sexual lifestyles and behaviours intended to prevent cervical cancer. Cochrane Database Syst Rev 2000;(2):CD001035.
8. American Academy of Family Physicians. Summary of recommendations for clinical preventive services. Revision 6.2, August 2006. Accessed October 12, 2006, at: http://www.aafp.org/online/etc/medialib/aafp_org/documents/clinical/ clin_recs/cps.Par.0001.File.tmp/August2006CPS.pdf.